The Modified S-GRAS Scoring System for Prognosis in Korean with Adrenocortical Carcinoma
- Author:
Sun Kyung BAEK
1
;
Seung Hun LEE
;
Seung Shin PARK
;
Chang Ho AHN
;
Sung Hye KONG
;
Won Woong KIM
;
Yu-Mi LEE
;
Su Jin KIM
;
Dong Eun SONG
;
Tae-Yon SUNG
;
Kyu Eun LEE
;
Jung Hee KIM
;
Kyeong Cheon JUNG
;
Jung-Min KOH
Author Information
- Publication Type:Original Article
- From:Endocrinology and Metabolism 2024;39(5):803-812
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Adrenocortical carcinomas (ACCs) are rare tumors with aggressive but varied prognosis. Stage, Grade, Resection status, Age, Symptoms (S-GRAS) score, based on clinical and pathological factors, was found to best stratify the prognosis of European ACC patients. This study assessed the prognostic performance of modified S-GRAS (mS-GRAS) scores including modified grade (mG) by integrating mitotic counts into the Ki67 index (original grade), in Korean ACC patients.
Methods:Patients who underwent surgery for ACC between January 1996 and December 2022 at three medical centers in Korea were retrospectively analyzed. mS-GRAS scores were calculated based on tumor stage, mG (Ki67 index or mitotic counts), resection status, age, and symptoms. Patients were divided into four groups (0–1, 2–3, 4–5, and 6–9 points) based on total mS-GRAS score. The associations of each variable and mS-GRAS score with recurrence and survival were evaluated using Cox regression analysis, Harrell’s concordance index (C-index), and the Kaplan–Meier method.
Results:Data on mS-GRAS components were available for 114 of the 153 patients who underwent surgery for ACC. These 114 patients had recurrence and death rates of 61.4% and 48.2%, respectively. mS-GRAS score was a significantly better predictor of recurrence (C-index=0.829) and death (C-index=0.747) than each component (P<0.05), except for resection status. mS-GRAS scores correlated with shorter progression-free survival (P=8.34E-24) and overall survival (P=2.72E-13).
Conclusion:mS-GRAS scores showed better prognostic performance than tumor stage and grade in Asian patients who underwent surgery for ACC.
